2670207

Source:http://linkedlifedata.com/resource/pubmed/id/2670207

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021756, umls-concept:C0278678, umls-concept:C0332293, umls-concept:C2603343
pubmed:dateCreated	1989-9-27
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7502030
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0305-7372
pubmed:author	pubmed-author:BijmanJ TJT, pubmed-author:FossåS DSD, pubmed-author:FranksC RCR, pubmed-author:IsraelLL, pubmed-author:JasminCC, pubmed-author:PalmerPP, pubmed-author:PhilipTT, pubmed-author:RugarliCC, pubmed-author:StoterGG, pubmed-author:SymannMM
pubmed:issnType	Print
pubmed:volume	16 Suppl A
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	111-3
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:2670207-Adult, pubmed-meshheading:2670207-Aged, pubmed-meshheading:2670207-Aged, 80 and over, pubmed-meshheading:2670207-Carcinoma, Renal Cell, pubmed-meshheading:2670207-Drug Evaluation, pubmed-meshheading:2670207-Female, pubmed-meshheading:2670207-Humans, pubmed-meshheading:2670207-Interleukin-2, pubmed-meshheading:2670207-Kidney Neoplasms, pubmed-meshheading:2670207-Male, pubmed-meshheading:2670207-Middle Aged, pubmed-meshheading:2670207-Multicenter Studies as Topic, pubmed-meshheading:2670207-Prognosis
pubmed:year	1989
pubmed:articleTitle	Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study.
pubmed:affiliation	Rotterdam Cancer Institute, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study